Cargando…
Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital
BACKGROUND: To study the effect of an ab interno gelatin stent (XEN45 Gel Stent, Allergan Inc., Irvine, California, USA) on intraocular pressure (IOP) as placed by glaucoma fellowship trainees in eyes with refractory glaucoma. METHODS: A prospective noncomparative study at a tertiary training center...
Autores principales: | Hong, Karen, Lind, John, Sheybani, Arsham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995155/ https://www.ncbi.nlm.nih.gov/pubmed/32021876 http://dx.doi.org/10.1186/s40662-019-0171-0 |
Ejemplares similares
-
Intraoperative suprachoroidal hemorrhage during Xen gel stent implantation
por: Liu, James C., et al.
Publicado: (2020) -
XEN(®)-63 Compared to XEN(®)-45 Gel Stents to Reduce Intraocular Pressure in Glaucoma
por: Evers, Charlotte, et al.
Publicado: (2023) -
Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation
por: Vera, Vanessa, et al.
Publicado: (2019) -
Long-Term Effectiveness of XEN 45 Gel-Stent in Open-Angle Glaucoma Patients
por: Marcos-Parra, Maria Teresa, et al.
Publicado: (2023) -
Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature
por: Panarelli, Joseph F, et al.
Publicado: (2023)